I derive great professional satisfaction from bringing improved solutions to health problems that have a big impact on people’s lives.”

Primary Areas of Expertise

Focus: Medtech and Health IT/Digital Health Companies

Strategic Advisory:

  • Go-to-market and growth strategy development, and implementation
  • Market analysis, strategy development, and execution
  • New Product development, and launch

Strategic Transactions:

  • Joint-venture, co-development, and commercialization partnering
  • Spin-out company design, execution and fundraising
  • M&A

Interim Leadership:

  • CEO/COO for early stage companies

Dean is a global business executive with over 25 years of leadership in turning innovation into value in the life sciences and healthcare. Dean has focused on the intersection of science, medical technology and business in general management, product development, technology commercialization, business development, strategic planning, and sales, marketing and operational roles in diverse settings ranging from venture capital-backed start-ups and spin-outs to major medical device, pharma and biotech companies in the U.S, Europe, and Asia. Bringing both strategic and entrepreneurial perspectives, Dean has assisted start-up, emerging and large, established companies to find and execute on new business opportunities across a broad range of diagnostic and therapeutic products in numerous diseases states. His experience includes leading development, commercialization and launch of novel products in diagnostic imaging, endoscopy, surgical instruments, stents and implantables, drug/device combinations, biologics, and pharmaceuticals, clinical informatics, medical image analysis machine/deep learning and predictive analytics, health IT and digital/mobile health segments.

Dean has run high-performing, customer-oriented businesses in a range of disease areas and markets including neurology and neurodegenerative diseases, ophthalmology, cardiovascular disease and stroke, general and specialty surgeries, oncology, diabetes, gastroenterology, urology and gynecology, sports medicine and orthopedics, regenerative medicine and liver disease and NASH.

Prior to joining TCG, Dean was a principal at Appareo LLC, a life science consulting firm specializing in market analysis and go-to-market strategy development. Previously he held senior roles with Heidelberg Engineering, an ophthalmic imaging company, where he led development and commercial efforts for a novel retinal optical coherence tomography biomarker in multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and other neurodegenerative diseases. From 2001 to 2003 Dean was Vice President, Global Marketing, Biosurgery at Sanofi Genzyme, responsible for Synvisc and Carticel regenerative medicine products. While at Boston Scientific Corporation from 1996 to 2001 he held several senior roles including Vice President, Strategic Planning, Microvasive Urology and Vice President, International Marketing for the Non-Vascular Group. Dean served as Business Director/General Manager for Surgical Skin Preparation, and Director, International Marketing, AcuteCare Division at Becton Dickinson (BD) from 1991 to 1996. Earlier, Dean was Regional Business Manager-Asia for pharmaceutical subsidiary planning and operations at Pfizer (formerly Lederle), and Director, International Sales and Marketing at Bios, Inc., a VC-backed nuclear cardiology start-up.

Dean’s business activities span all major global healthcare markets. He provides a global perspective with expatriate experience and foreign language skills. Dean received his B.A. from Earlham College and M.A. in International Business from Columbia University.